What Does Cooper Companies (COO) Do? - Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Overview
Cooper Companies (COO) is a global medical device company operating contact lenses and women's health medical devices. Its stable recurring revenue from contact lenses, growth in pediatric myopia management lenses, the women's health and fertility market, and FX volatility are cited as the core drivers of earnings and stock outlook.
🏢 What kind of company is Cooper Companies?
Cooper Companies (COO) is a global medical device company that operates a vision correction business centered on contact lenses and medical devices related to women's health and fertility treatment. Its two main pillars are everyday contact lenses and obstetrics/gynecology and fertility treatment devices.
The business is divided into a contact lens segment and a women's health segment. The contact lens segment, including daily disposable and myopia management lenses, accounts for a large share of revenue, while the women's health segment supplies devices and consumables related to obstetrics/gynecology and fertility treatment. Because contact lenses are consumables that are replaced on a regular basis, they provide a stable base of recurring revenue.
💰 How does Cooper Companies make money?
| Business Segment | Revenue Share | Description |
|---|---|---|
| Contact Lenses | Core | Core segment generating a large share of revenue from contact lenses, including daily disposable and myopia management lenses |
| Women's Health | Diversification Pillar | Segment providing devices and consumables related to obstetrics/gynecology and fertility treatment |
| Myopia Management | Expanding | Growth area including lenses that slow the progression of myopia in children |
Contact lenses account for a large share of Cooper Companies' revenue, complemented by the women's health segment. Because contact lenses are consumables that are replaced on a regular basis, they provide a stable base of recurring revenue, and myopia management lenses that slow the progression of myopia in children are a rapidly growing area. The women's health segment grows on the back of fertility treatment demand. With a large share of global business, FX volatility affects earnings, and the company pursues growth through new products and overseas expansion.
📐 Cooper Companies Market Cap and Company Scale
Market cap stands at $14.2B, and the employee headcount is not publicly disclosed.
Cooper Companies is one of the largest medical device companies in the global contact lens market, holding both daily disposable and myopia management lenses and women's health and fertility treatment devices. Backed by stable recurring revenue from contact lenses and rapidly growing myopia management lenses, the company is in a growth phase driven by new products and overseas expansion.
📈 Cooper Companies Outlook and Stock Price Trends
Medium- to long-term drivers include growing contact lens demand, the expansion of pediatric myopia management lenses, and rising fertility treatment demand. As the myopic population grows, demand for myopia management lenses is increasing rapidly, while the shift toward daily disposable lenses and fertility treatment demand also form part of the growth foundation. The consumable nature of contact lenses adds to revenue stability. However, global FX volatility, intensifying competition, demand shifts driven by a consumer slowdown, and rising input costs may act as short-term earnings variables.
- Contact lens demand and pediatric myopia management lens growth
- Expansion of women's health demand, including fertility treatment
- New products and overseas market expansion
⚔️ Cooper Companies Core Competitive Strengths and Risks
Stable recurring revenue from contact lenses, myopia management growth, and women's health diversification are strengths, while FX volatility, competition, and a consumer slowdown are the key risks.
💪 Core Competitive Strengths
⚠️ Key Risks
🔄 Cooper Companies Competitors and Related (Beneficiary) Stocks
Within the ophthalmology and medical device space, Cooper Companies is compared alongside other medical device companies. ALC in ophthalmic devices and lenses and BLCO in ophthalmology and consumer health are frequently mentioned as comparable peers in the same business domain.
| 종목 | 회사명 | 가격 | 등락 | 시총 | PER | PBR | ROE | 배당률 |
|---|---|---|---|---|---|---|---|---|
| ALC | Alcon Inc | $69.61 | -0.1% | $33.9B | 42.0 | 1.5 | 3.71% | 0.5% |
 BLCO | Bausch + Lomb Corp | $16.99 | +4.9% | $6.1B | - | 0.9 | -2.67% | - |
✅ Cooper Companies Investor Checkpoints
Cooper Companies is a global medical device company operating contact lenses and women's health medical devices. Its stable recurring revenue and myopia management growth are appealing, but investors should also review FX volatility and competitive variables. The company has 15,000명 employees.
| Checkpoint | What to Confirm | Current Status |
|---|---|---|
| 👁️ Contact Lenses | Contact lens demand and myopia management lens growth | Core Growth Driver |
| 🤰 Women's Health | Women's health segment demand, including fertility treatment | Diversification Driver |
| 💱 FX and Competition | Global FX volatility and competition | Volatility Factor |
Global FX volatility, intensifying competition in the contact lens market, demand shifts driven by a consumer slowdown, and rising input costs may affect earnings, so it is necessary to look at contact lens and myopia management growth together with women's health demand.
Cooper Companies is a global medical device company with stable recurring revenue from contact lenses, myopia management growth, and women's health diversification, but given FX volatility, competition, and a consumer slowdown, a medium- to long-term perspective is advisable.
이 글은 2026년 6월 4일 기준 정보입니다.